SPY332.21-1.98 -0.59%
DIA273.66-2.24 -0.81%
IXIC11,092.22-25.31 -0.23%

Flexion Therapeutics Sees Prelim. Q4 Sales $23.7M vs $24.15M Est., Prelim. FY19 Sales $73M vs $73.43M Est.; Sees FY20 Product Revenues $120M-$135M

Benzinga · 01/09/2020 21:03